Molecular Signatures of Blood Biomarkers in Depression: Gene Expression Analysis of <i>GAR1, PER3, MTPAP, SLC25A26</i>, and <i>CD19</i>, a Case-Control Study.

Diagnostics (Basel) · 2026 · PMC13025220 · PMID 41897616

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

moderately significantno p-value reported

Among the five selected genes ( GAR1 , PER3 , MTPAP , SLC25A26 , and CD19 ), only one gene, GAR1 , showed moderately significant upregulation, while PER3 , MTPAP , SLC25A26 , and CD19 were significantly upregulated in the patients’ group when compared to the healthy controls with fold change value (PER3: 2.42, CD19: 6.15, MTPAP: 3.99, SLC25A26: 1.24).

also in 2,174 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

Molecular Signatures of Blood Biomarkers in Depression: Gene Expression Analysis of &lt;i&gt;GAR1, PER3, MTPAP, SLC25A26&lt;/i&gt;, and &lt;i&gt;CD19&lt;/i&gt;, a Case-Control Study.

The sentences

Molecular Signatures of Blood Biomarkers in Depression: Gene Expression Analysis of <i>GAR1, PER3, MTPAP, SLC25A26</i>, and <i>CD19</i>, a Case-Control Study.